The global demand for In Vitro Diagnostics Market is presumed to reach the market size of nearly USD 258.03 BN by 2030 from USD 229.06 BN in 2022 with a CAGR of 1.5% under the study period of 2023 - 2030. Regarding volume, the market was calculated XX Thousands for Instruments & Million in 2022 and forecast to touch XX Thousands for Instruments & Million by 2030 with a CAGR of XX% during 2023-2030.
In Vitro Diagnostics or IVD are medical devices which are used to perform diagnostic tests on samples such as blood, urine, tissues and other bodily fluids obtained from the human body to diagnose diseases, conditions, and infections. The IVD test help detects and monitors medical disorders, such as infectious diseases, diabetes, oncology/cancer, cardiac diseases, autoimmune diseases, nephrology, HIV/AIDS, and several medical conditions that are being used to analyze drug therapies.
The rise in the occurance of infectious diseases, such as gastrointestinal, respiratory, and STDs is the major reason for the growth of the IVD market under the study period. Moreover, increasing adoption of fully automated instruments in diagnostic laboratories helps decrease the hands-on time of technologists, eliminates batch testing, and delivers faster results to physicians and continues to grow as new manufacturers enter the market with greater automation possibilities. Furthermore, technological advancements such as rapid test kits for the IVD industry have expanded at an astounding rate in recent years and are expected to continue. The high sensitivity and specificity of these tests have scaled up their demand. The unclear reimbursement scenarios and strict policies are expected to impede the market's growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vitro diagnostics. The growth and trends of In Vitro Diagnostics Industry provide a holistic approach to this study.
This section of the in vitro diagnostics market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By Technology
By Application
By End-Use
By Test Location
This section covers the regional outlook, which accentuates current and future demand for the In Vitro Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in vitro diagnostics market include Abbott, bioMérieux SA, Bio-Rad Laboratories Inc., Siemens Healthineers, Qiagen, Quidel Corp., F. Hoffmann-La Roche Ltd., Sysmex Corp., Charles River Laboratories, Quest Diagnostics, Agilent Technologies Inc., Danaher Corp., Becton Dickinson and Company. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Avail customized purchase options to meet your exact research needs: